Characterization of Potential Drug Targets Farnesyl Diphosphate Synthase and Geranylgeranyl Diphosphate Synthase in Schistosoma mansoni

Schistosomiasis affects over 200 million people worldwide, with over 200,000 deaths annually. Currently, praziquantel is the only drug available against schistosomiasis. We report here that Schistosoma mansoni farnesyl diphosphate synthase (SmFPPS) and geranylgeranyl diphosphate synthase (SmGGPPS) a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ziniel, Peter D., Desai, Janish, Cass, Cynthia L., Gatto, Craig, Oldfield, Eric, Williams, David L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837879/
https://ncbi.nlm.nih.gov/pubmed/24041901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00699-13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak